NF1 and neoplasm: More importantly, loss of PRC2 function and concomitant inactivation of the tumor suppressor genes NF1 and CDKN2A are considered to be the most significant diagnostic markers of MPNST in the revised 2016 WHO Classification of Tumors of the Central Nervous System (17, 18).